Articles
Volume 2 (2004) - September 2004
|
Mark Booth, Birgitte J Vennervald, Anthony E Butterworth, Henry C Kariuki, Clifford Amaganga, Gachuhi Kimani, Joseph K Mwatha, Amos Otedo, John H Ouma, David W Dunne BMC Medicine 2004, 2:36 (27 September 2004) The outcome of the treatment with praziquantel of the hepatosplenomegaly associated with schistosomaisis is adversely affected by the level of malaria exposure, highlighting the need to reassess the estimates and control of Schistosoma mansoni related morbidity.
|
|
Richard A Malthaner, Rebecca KS Wong, R Bryan Rumble, Lisa Zuraw, Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. BMC Medicine 2004, 2:35 (24 September 2004) A systematic review on the use of adjuvant and neoadjuvant therapy on esophageal cancer shows that surgery alone is the optimal treatment for those patients for whom a complete resection is possible.
|
|
Maria M Medveczky, Tracy A Sherwood, Thomas W Klein, Herman Friedman, Peter G Medveczky BMC Medicine 2004, 2:34 (15 September 2004) In cell cultures, the active ingredient of cannabis, delta-9-tetrahydrocannibol (THC), can inhibit the replication and activation of several gamma herpesviruses, including two that are associated with human tumors.
|
|
Kathleen McKibbon, Nancy L Wilczynski, Robert Haynes BMC Medicine 2004, 2:33 (6 September 2004) An assessment of 60,000 articles from 170 healthcare journals finds that the majority of clinically useful articles in each discipline are published in a small subset of journals.
|
|
Karin Nygård, Birgitta de Jong, Philippe J Guerin, Yvonne Andersson, Agneta Olsson, Johan Giesecke BMC Medicine 2004, 2:32 (2 September 2004) A comprehensive database containing details of infections caught abroad by travellers could be used to highlight emerging infections worldwide and inform countries that have limited surveillance systems about possible disease outbreaks.
|

